Sienna Biopharmaceuticals, Inc. Current Liabilities
Sienna Biopharmaceuticals, Inc. had Current Liabilities of $1.29 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2019-11-12
- 2019-09-30: Liabilities, Current $1.29M.
- 2019-06-30: Liabilities, Current $20.81M.
- 2019-03-31: Liabilities, Current $22.45M.
- 2018-12-31: Liabilities, Current $24.35M.
| Period end | Liabilities, Current |
|---|---|
| 2019-09-30 | $1.29M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $20.81M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $22.45M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $24.35M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $13.81M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $13.35M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $9.12M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $8.24M 10-K · filed 2019-03-14 |
| 2017-09-30 | $13.51M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $11.75M 10-Q · filed 2017-09-07 |
| 2016-12-31 | $9.88M 10-K · filed 2018-03-15 |